Categories: DNANewsPharmaceutical

Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro Summit

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

IRVINE, Calif., Oct. 06, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, today announced that the company’s management team will participate in the Jefferies Biotech CNS/Neuro Summit.

Jefferies Biotech CNS/Neuro Summit
Date: Wednesday, October 11, 2023
Location: Jefferies Conference Center, New York, NY

About Reneo Pharmaceuticals
Reneo is a clinical-stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). Our lead product candidate, mavodelpar (REN001), is a potent and selective agonist of the peroxisome proliferator-activated receptor delta (PPARδ). Mavodelpar has been shown to increase transcription of genes involved in mitochondrial function, increase fatty acid oxidation, and may increase production of new mitochondria. For additional information, please see reneopharma.com.

Contacts:

Danielle Spangler
Investor Relations
Reneo Pharmaceuticals, Inc.
dspangler@reneopharma.com

Matthew Purcell, Pharm.D.
Media Inquiries
Russo Partners, LLC
matthew.purcell@russopartnersllc.com

Staff

Recent Posts

Proper Good, Inc. Successfully Secures New Funding to Fuel Growth

AUSTIN, Texas, Jan. 13, 2025 /PRNewswire/ --  Proper Good, Inc., a leader in ready-to-eat meal solutions,…

2 hours ago

Ex-Deep Genomics, Moderna Execs Get Backing Led by Gradient to Develop Next-Generation mRNA Therapeutics with AI

SAN FRANCISCO, Jan. 13, 2025 /PRNewswire/ -- Kerna Laboratories Inc, a San Francisco-based AI biotech startup,…

2 hours ago

Ventra Health Appoints Sarah Herzog President of Radiology as ADVOCATE RCM Integration is Completed

Former ADVOCATE RCM Head of Operations to Lead Radiology Business Unit Focused on Optimizing Performance…

2 hours ago

Human Longevity, Inc. and SleepScore Labs Partner to Launch AI Driven Personalized Precision Sleep Program

SOUTH SAN FRANCISCO, Calif., Jan. 13, 2025 /PRNewswire/ -- Human Longevity, Inc. (HLI) and SleepScore…

2 hours ago

EDETEK Unveils Revolutionary Life Sciences R&D Cloud for Clinical Development

Unveiling the next generation paradigm in Clinical Data Sciences PRINCETON, N.J., Jan. 13, 2025 /PRNewswire/…

2 hours ago

Vevo Therapeutics to Open Source Milestone Tahoe-100M Dataset

Tahoe-100M is the world's largest single-cell atlas of how drug molecules impact biology of patient…

2 hours ago